Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
106 studies found for:    cancer | butyrate
Show Display Options
RSS Create an RSS feed from your search for:
cancer | butyrate
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Conditions: Leukemia;   Lymphoma;   Precancerous Condition;   Small Intestine Cancer
Interventions: Drug: arginine butyrate;   Drug: ganciclovir
2 Terminated Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
Conditions: Lymphoid Malignancies;   Lymphoproliferative Disorders
Interventions: Drug: HQK-1004;   Drug: Valganciclovir (may substitute with ganciclovir)
3 Completed Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
Conditions: Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: chemotherapy;   Drug: tributyrin
4 Completed Effect of Annona Muricata Leaves on Colorectal Cancer Patients and Colorectal Cancer Cells
Condition: Colorectal Cancer
Interventions: Dietary Supplement: Annona muricata extract;   Dietary Supplement: Placebo
5 Terminated Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
Conditions: EBV Lymphomas;   Lympho-proliferative Diseases
Interventions: Drug: Arginine Butyrate;   Drug: Ganciclovir;   Drug: Valganciclovir
6 Recruiting Microbiome, Exercise Tracking Study (METS)
Condition: Colorectal Cancer
Intervention: Behavioral: Physical activity intervention
7 Completed
Has Results
A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
Conditions: Hypertension;   Brain Tumor;   Epilepsy
Intervention: Drug: Clevidipine
8 Recruiting Relaxation for Women With Breast Cancer Undergoing Radiotherapy
Condition: Breast Cancer
Interventions: Other: Relaxation Program;   Behavioral: Questionnaires;   Other: Saliva Testing
9 Active, not recruiting Mindfulness Based Couples Therapy
Condition: Breast Cancer
Interventions: Behavioral: Mindfulness-Based Relationship Enhancement (MBRE);   Behavioral: Self-Help Materials;   Behavioral: Pain Assessment;   Behavioral: Questionnaires;   Behavioral: Neurocognitive Tests;   Procedure: Cortisol Tests;   Behavioral: Interviews
10 Completed Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: sargramostim;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
11 Terminated
Has Results
Saracatinib in Treating Patients With Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: saracatinib;   Other: hydrocortisone/placebo
12 Completed
Has Results
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: vismodegib;   Drug: gemcitabine hydrochloride;   Other: hydrocortisone/placebo
13 Terminated A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: aminoglutethimide;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
14 Completed Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Other: Withdrawal of antiandrogen therapy
15 Completed Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
16 Active, not recruiting Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Cervical Intraepithelial Neoplasia Grade 2;   Cervical Intraepithelial Neoplasia Grade 3
Interventions: Other: hydrocortisone/placebo;   Drug: celecoxib
17 Withdrawn Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Condition: Prostate Cancer
Interventions: Drug: dexamethasone;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Procedure: pharmacological study
18 Recruiting Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Condition: Pituitary Neoplasms
Interventions: Drug: Dexmedetomidine;   Drug: Sodium Chloride 0.9%
19 Terminated Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: hydrocortisone;   Drug: dutasteride;   Drug: lapatinib
20 Completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: suramin;   Drug: therapeutic hydrocortisone;   Procedure: orchiectomy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.